Democritus University of Thrace (DUTH)
Αλληλεπίδραση μεταβιβαστών φλεγμονής και κυτταρικών πληθυσμών του αναπνευστικού επιθηλίου στην παθογένεια της ιδιοπαθούς πνευμονικής ίνωσης
Abstract
dc:descriptionIdiopathic pulmonary fibrosis (IPF) is a progressive fibrotic lung disease of unknown cause that leads to respiratory failure and death within 3-5 years of diagnosis. The exact triggers, which initiate the fibrotic process, remain unknown. IPF is characterized by myofibroblast recruitment and activation/excessive collagen secretion. Accumulated myofibroblasts, stimulated locally, express enhanced fibrotic activity. Tumor necrosis factor- Like cytokine 1 A (TL1A), a member of the TNF-α superfamily, is a novel fibrogenic factor, which plays a major role in inflammatory bowel disease pathogenesis. Its role in IPF has never been investigated. Our aim was to explore: 1) The possible role of pro-fibrotic responses of human Subepithelial Lung Myofibroblasts (SELM) in the development of fibrosis in IPF patients and controls, and 2) The role of TL1A in the pathogenesis of IPF. SELM were isolated from surgical specimens of healthy lung tissue and cultured, stimulated or unstimulated, with pro-inflammatory cytokines (rhTNF-α, rhIL-1α and rhIFN-g) added alone or in combination and with bronchoalveolar lavage fluid (BALF) from patients with IPF or idiopathic non- specific interstitial pneumonia (iNSIP) and controls (non-ILD). Fibrotic activity of HLM was assessed through collagen production in culture supernatants and the wound healing method. In addition, total RNA was extracted from Subepithelial Lung Myofibroblasts (SELM), mRNA was processed for tissue factor (TF) and TL1A protein with RT-PCR. TL1A levels were accessed by immunochemistry. Data were presented as the mean ± standard deviation of the mean (SD) of at least 3 independent experiments. Comparative statistical evaluation between groups was performed by ANOVA Bonferroni t post-hoc analysis and Student's t-test were used for statistical comparison between individual variables, as appropriate. Statistical significance was established at a level of p < 0.05.In the present study, we found that SELM stimulation with IPF-BALF (n=3) or with the combination of cytokines (IL-1α+TNF-α+IFN-γ) produced a statistically significant increase of collagen levels (IPF1: 183.99 μg/ml±14.03, p<0.01, IPF2: 118.50 μg/ml±5.04, p<0.05, IPF3: 126.23 μg/ml±2.7, p<0.05 and 3C: 184.72 μg/ml±29.72, p<0.05 compared to unstimulated: 63 μg/ml±1.2). In addition, stimulation of SELM with BALF-IPF or with pro- inflammatory cytokines (IL-1α, TNF-α) demonstrated a significant increase in the transcription activity of TF (IPF: 3.56-fold±0.14, IL-1α: 2.5-fold±0.08, TNF-α: 2.3-fold±0.007, 2C: 2.7-fold±0.17, p<0.05 compared to unstimulated: 1.1-fold±0.3) and TL1A (IPF: 6.5-fold±0.8, IL-1α: 156-fold±14.94, TNF-α: 240- fold±7.8, 2C: 116-fold±3.6, p<0.01 compared to unstimulated: 1.3-fold±0.6). TL1A levels were confirmed by immunofluorescence. This is the first time TL1A has been measured in lung SELM. Finally, stimulation of SELM with pro-inflammatory cytokines didn’t induce any significant increase in migratory activity in contrast to stimulation with BALF (IPF2: 43.69%±2.16, p<0.01, IPF3: 36.49%±2.37, p<0.05).In conclusion, the BALF from patients with IPF induces the fibrotic activity of a pro-fibrotic activity in human lung myofibroblasts of the patients with IPF, in the same manner the fibrotic mediators that are related to pulmonary fibrosis, suggesting a crucial role for the subepithelial myofibroblasts in IPF. TL1A cytokine is a major pro-inflammatory cytokine that is abundantly expressed in fibrotic lesions and induces a pro-fibrotic activity in human lung myofibroblasts of the patients with IPF. Similar results were observed after BALF_IPF stimulation, indicating the significance of myofibroblasts in IPF.
Degree
thesis:*- Grantor dc:publisher
- Democritus University of Thrace (DUTH)
- Year dc:date
- 2018
Author and committee
dc:creator, dc:contributor.*- Authors dc:creator
-
- Bouros, Evangelos
- Μπούρος, Ευάγγελος
Subjects
dc:subject × 23- Ιδιοπαθής πνευμονική ίνωση
- Παθογένεια
- Μυοϊνοβλάαστες
- Κολλαγόνο
- Διάχυτες διάμεσες πνευμονοπάθειες
- Ιδιοπαθείς διάμεσες πνευμονίες
- Ουλοποίηση
- Βρογχοκυψελιδικό έκπλυμα
- Επούλωση πληγής
- Κυτταροκαλλιέργεια
- Επώαση
- Βρογχοσκόπηση
- Idiopathic pulmonary fibrosis (IPF)
- Myofibroblasts
- TNFa
- TNF-like cytokine 1A (TL1A)
- Collagen
- Bronchoalveolar lavage ( BAL )
- Pathogenesis
- Ιατρική και Επιστήμες Υγείας
- Κλινική Ιατρική
- Medical and Health Sciences
- Clinical Medicine
Rights
dc:rights- Statement dc:rights
-
- BY
- Language dc:language
- gre
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/42791